Condition
HPV Vaccine Knowledge
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06683664Not ApplicableNot Yet Recruiting
HPV Vaccine Integrated Service Implementation Research in Cameroon
NCT06667323Not ApplicableNot Yet Recruiting
HPV Vaccine Integrated Service Implementation Research in Ethiopia
NCT04766164CompletedPrimary
Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults
Showing all 3 trials